The Department of Veterans Affairs (VA) awarded a firm fixed price purchase order to Illumina, Inc. for $572,616.60 to provide specialized next-generation sequencing reagents to support the Minneapolis VA Health Care System's Oncology Strategic Initiative. The contract has a base period with four option years, and the reagents will be used on MiniSeq and NextSeq 550 sequencers. Illumina is the sole manufacturer and distributor of the required AmpliSeq Myeloid Panel, AmpliSeq Library PLUS, AmpliSeq UD Index, and MiniSeq Mid-Output Kits. The procurement is not set aside for any specific business category. Illumina has provided sequencing systems and reagents to support genomic research and diagnostics for various federal agencies including the NIH, CDC, USDA, and VA.
Generated 3/13/25, 10:09 AM